MoneyWorks4Me

The sales declined to Rs. 214.44 millions for the June 2024 quarter as compared to Rs. 254.30 millions during the corresponding quarter last year.Net profit surges 69.37% to Rs. 51.25  millions  from Rs. 30.26 millions in the quarter ended June 2024.The company reported a good operating profit of 57.03 millions compared to 32.91 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 214.44 254.30 -15.67 214.44 254.30 -15.67 1087.39 924.36 17.64
Other Income 51.60 44.39 16.24 51.60 44.39 16.24 148.74 99.27 49.83
PBIDT 57.03 32.91 73.29 57.03 32.91 73.29 230.18 174.85 31.64
Interest 0.53 0.17 211.76 0.53 0.17 211.76 3.89 2.23 74.44
PBDT 56.68 33.02 71.65 56.68 33.02 71.65 226.29 172.62 31.09
Depreciation 5.43 2.76 96.74 5.43 2.76 96.74 19.55 13.28 47.21
PBT 51.25 30.26 69.37 51.25 30.26 69.37 206.74 159.34 29.75
TAX 0.00 0.00 0.00 0.00 0.00 0.00 38.97 33.08 17.81
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 1.13 -2.88 -139.24
PAT 51.25 30.26 69.37 51.25 30.26 69.37 167.77 126.26 32.88
Equity 210.41 210.41 0.00 210.41 210.41 0.00 210.41 210.41 0.00
PBIDTM(%) 26.59 12.94 105.50 26.59 12.94 105.50 21.17 18.92 11.91
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..